# FDA WARNING_LETTER - Atmos Nation LLC d/b/a AtmosRx - April 07, 2020

Source: https://www.keypedia.com/records/warning_letter/atmos-nation-llc-dba-atmosrx/c9687f21-81bf-4d07-9584-762c73a04e92

> FDA WARNING_LETTER for Atmos Nation LLC d/b/a AtmosRx on April 07, 2020. Product: Tobacco. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Atmos Nation LLC d/b/a AtmosRx
- Inspection Date: 2020-04-07
- Product Type: Tobacco
- Office Name: Center for Tobacco Products
- Summary: The FDA's Center for Tobacco Products issued a Warning Letter to Charly Benassayag and Eli Eroch regarding e-liquid products advertised and sold on atmosrx.com. The FDA determined these e-liquids are tobacco products under section 201(rr) of the FD&C Act. The primary violation is that several e-liquid products are misbranded under section 903(a)(7)(B) of the FD&C Act because their advertising on the website fails to include the required nicotine warning statement, as mandated by 21 C.F.R. § 1143.3(b). Specifically, the advertising did not bear the warning: "WARNING: This product contains nicotine. Nicotine is an addictive chemical." The letter emphasizes that e-liquids are considered "covered tobacco products" subject to these regulations. The company must immediately correct these violations and submit a written response within 15 working days, detailing corrective actions, dates of discontinuing violative advertising/sales, and a plan for future compliance. Failure to comply may result in severe FDA enforcement actions, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, injunction, and detention of imported products.

## Related Officers

- [Director](https://www.keypedia.com/people/ann-simoneau/155ef03c-6b60-4063-b35d-75522fa67d2b)

Company: https://www.keypedia.com/companies/atmos-nation-llc-dba-atmosrx/030b7824-01e3-4e7c-b0ce-aa2426c8aa4c

Office: https://www.keypedia.com/offices/center-for-tobacco-products/65f73cae-ef6f-4e9f-a311-a111daa67374